MP:0002398 | abnormal bone marrow cell morphology/development | "anomalous structure or formation of the cells found in the bone marrow" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0002451 | abnormal macrophage physiology | "abnormal function or response of the phagocytic leukocytes involved in innate immunity, early non-adaptive phases of host-defense, antigen presentation, and which act as effector cells in humoral and cell-mediated immunity" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0002495 | increased IgA | "greater than normal immunoglobulin class A level" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0002497 | increased IgE | "greater than normal immunoglobulin class E level" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0005165 | increased susceptibility to injury | "greater than the normal reaction to trauma, especially that by physical means" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0008500 | increased IgG2a level | "greater than normal immunoglobulin class G2a level" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0008501 | increased IgG2b level | "greater than normal immunoglobulin class G2b level" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0008566 | increased interferon-gamma secretion | "increase in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0008609 | decreased circulating interleukin-13 level | "reduction in the amount in the blood of a cytokine synthesized by T-cells that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-cells, and appears to play a role in regulating inflammatory and immune responses" [MESH:D12.644.276.374.465.513] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0008660 | increased interleukin-10 secretion | "increase in the production or release of a cytokine produced by a variety of cell types, including T-cells, monocytes, dendritic cells and epithelial cells that exerts a variety of effects on immunoregulation and inflammation" [MESH:D12.644.276.374.465.510] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0008700 | decreased interleukin-4 secretion | "reduction in the production or release of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0008734 | decreased susceptibility to endotoxin shock | "less than the expected early reaction of the microcirculation to endotoxins such as LPS, characterized by movement of fluid and leukocytes from the blood into extravascular tissues and often resulting in death" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0008973 | decreased erythroid progenitor cell number | "reduced numbers of progenitors of the erythrocyte lineage" [CL:0000038, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Lipgtm1Chan/Lipg+ Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
|
MP:0020344 | abnormal susceptibility to injury induced morbidity/mortality | "differences from the expected moribund state caused by trauma, especially that by physical means" [ORCID: orcid.org/0000-0003-4606-0597] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|
MP:0030002 | increased lung apoptosis | "acceleration in the timing or in the number of cells of the lung undergoing programmed cell death" [ORCID:orcid.org/0000-0002-6490-7723, PMID:17589521] |
Show
Allelic Composition: Apptm1.1Wevn/Apptm1.1Wevn Genetic Background: B6.129S6(FVB)-Apptm1.1Wevn
|